Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registryMaria Mazzitelli, Laura Comi, Chiara Fornabaio et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 7
Long-term outcome in a person with pandrug-resistant HIV: the added value of a multidisciplinary approachTommaso Clemente, Vincenzo Spagnuolo, Diana Canetti et al.|JAC-Antimicrobial Resistance|2024Cited by 1
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO RegistryDaniele Armenia, Silvia Magnani, Giovanni Marchegiani et al.|Journal of Antimicrobial Chemotherapy|2025Cited by 0